Halozyme Therapeutics, INC.
SEC CIK 1159036 · Halo · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Krishnan Mahesh | Director | filed 2024 - 2026 |
| Torley Helen | Director · President and CEO | filed 2014 - 2026 |
| Connaughton Bernadette | Director | filed 2018 - 2026 |
| Henderson Jeffrey William | Director | filed 2015 - 2026 |
| Duncan Barbara Gayle | Director | filed 2023 - 2026 |
| Posard Matthew L. | Director | filed 2013 - 2026 |
| Lang James Paul | Director | filed 2026 - 2026 |
| Miyashita Akiko Moni | Director | filed 2022 - 2025 |
| Matsui Connie | Director | filed 2006 - 2024 |
| Daly James M | Director | filed 2016 - 2023 |
| Bizzari Jean-Pierre | Director | filed 2015 - 2023 |
| Kelley Kenneth J | Director | filed 2006 - 2021 |
| Kirk Randal J | Director | filed 2006 - 2018 |
| Falberg Kathryn E | Director | filed 2007 - 2016 |
| Patton John Stuart | Director | filed 2006 - 2014 |
| Engler Robert | Director | filed 2006 - 2014 |
| Frost Gregory Ian | Director · VP, Chief Scientific Officer | filed 2007 - 2013 |
| Lim Jonathan E | Director · President, CEO | filed 2007 - 2010 |
| Thornton Steven T | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Snyder Mark Howard | SVP, General Counsel | filed 2022 - 2026 |
| Snellgrove Darren | SVP, Chief Financial Officer | filed 2026 - 2026 |
| Ramsay David A | VP, Chief Financial Officer | filed 2007 - 2026 |
| Caudill Cortney | SVP, CHIEF OPERATING OFFICER | filed 2025 - 2026 |
| Labrosse Nicole | SVP, Chief Financial Officer | filed 2022 - 2026 |
| Labarre Michael J. | VP, Product Development | filed 2010 - 2025 |
| Matsuda Masaru | SVP, General Counsel | filed 2020 - 2021 |
| Sun Elaine D | SVP, Chief Financial Officer | filed 2020 - 2021 |
| Stelzer Laurie | SVP, Chief Financial Officer | filed 2015 - 2020 |
| Hickey Benjamin | SVP, Chief Commerical Officer | filed 2018 - 2019 |
| Chondros Dimitrios | SVP, Chief Medical Officer | filed 2018 - 2019 |
| Armour Alison A. | SVP, Research & Development | filed 2019 - 2019 |
| Leonhardt Harry J | SVP, GC and CCO | filed 2015 - 2019 |
| Gergen Mark J | SVP, Chief Operating Officer | filed 2016 - 2017 |
| Countouriotis Athena | SVP and Chief Medical Officer | filed 2015 - 2017 |
| LIU Jean I | VP & General Counsel | filed 2011 - 2014 |
| Shaffer James P | VP, Chief Commercial Officer | filed 2011 - 2014 |
| Shepard H. Michael | VP, Chief Scientific Officer | filed 2010 - 2013 |
| Gustafson Kurt A | Vice President, Finance | filed 2009 - 2013 |
| Fallon William J | Vice President, Mfg. and Ops | filed 2006 - 2011 |
| Little Robert J | VP-Chief Commercial Officer | filed 2006 - 2010 |
| Leff Jonathan A | VP, Chief Medical Officer | filed 2009 - 2009 |
| Yocum Richard C | VP-Clinical Development | filed 2007 - 2008 |
| Hooper Matthew | Vice Pres & General Counsel | filed 2007 - 2007 |
| Kennard Don A | Vice President, Regulatory Aff | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.